Candel director reports no CADL share holdings

Candel Therapeutics, Inc. (CADL) reported that Martine Zimmermann, a director of the company, filed an initial statement of beneficial ownership on Form 3.

Rhea-AI Filing Summary

Candel Therapeutics, Inc. (CADL) reported that Martine Zimmermann, a director of the company, filed an initial statement of beneficial ownership on Form 3. The filing lists no equity holdings or reportable transactions in Candel Therapeutics securities at this time.

Key Figures

Reported purchases: 0 transactions Reported sales: 0 transactions Holding entries: 0 entries

3 metrics

Reported purchases 0 transactions Buy transactions reported for Martine Zimmermann on this Form 3

Reported sales 0 transactions Sell transactions reported for Martine Zimmermann on this Form 3

Holding entries 0 entries Number of holdings listed for Martine Zimmermann

Key Terms

Form 3, beneficial ownership, Power of Attorney

3 terms

Form 3 regulatory

"filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership regulatory

"filed an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney;"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

What does the Form 3 filed for CADL by Martine Zimmermann show?

The Form 3 for Candel Therapeutics (CADL) filed by director Martine Zimmermann reports no equity holdings and no reportable transactions in the company’s securities as of the filing’s reporting date.

Is Martine Zimmermann an officer or only a director at Candel Therapeutics (CADL)?

The filing identifies Martine Zimmermann as a director of Candel Therapeutics, Inc. and not as an officer. The officer status box is not marked, and no officer title is provided.

Does the CADL Form 3 for Martine Zimmermann report any purchases or sales?

No. The transaction summary in the Form 3 shows 0 purchases, 0 sales, and no other reportable transactions in Candel Therapeutics securities for Martine Zimmermann.

Are any derivative securities reported for Martine Zimmermann in CADL?

No. The Form 3 lists no derivative securities for Martine Zimmermann; the derivative securities section is empty and the derivative transaction count is zero.

What additional document is referenced in the CADL Form 3 for Martine Zimmermann?

The remarks section references “Exhibit 24 - Power of Attorney”, indicating that a Power of Attorney document is associated with the Form 3 filed for Martine Zimmermann.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:22 PM Accepted by SEC EDGAR 09/10/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zimmermann Martine

(Last) (First) (Middle)

C/O CANDEL THERAPEUTICS, INC.

117 KENDRICK ST., SUITE 450

(Street)

NEEDHAM MASSACHUSETTS 02494

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/08/2026

3. Issuer Name and Ticker or Trading Symbol
Candel Therapeutics, Inc. [ CADL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney;

No securities are beneficially owned.

	/s/ Charles Schoch, as Attorney-In-Fact for Martine Zimmermann	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)